Chronix Biomedical Opens New Disease Biomarker Operation

Chronix Biomedical has opened a new state-of-the-art mass sequencing center to support the biomarker programs of academic and biopharmaceutical researchers. Chronix believes its proprietary technology will enable the rapid identification of disease biomarkers and is positioning the new center to focus on rare and orphan diseases, including ALS.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail